Page last updated: 2024-10-19

orotic acid and Injury, Ischemia-Reperfusion

orotic acid has been researched along with Injury, Ischemia-Reperfusion in 1 studies

Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.

Research Excerpts

ExcerptRelevanceReference
"The study provides experimental evidence that the combination of orotic acid and mildronate possesses additive pharmacological effects and that mildronate orotate might be considered as a powerful therapeutic agent facilitating recovery from ischemia-reperfusion injury."3.75Myocardial infarct size-limiting and anti-arrhythmic effects of mildronate orotate in the rat heart. ( Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Veveris, M; Vilskersts, R, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vilskersts, R1
Liepinsh, E1
Kuka, J1
Cirule, H1
Veveris, M1
Kalvinsh, I1
Dambrova, M1

Other Studies

1 other study available for orotic acid and Injury, Ischemia-Reperfusion

ArticleYear
Myocardial infarct size-limiting and anti-arrhythmic effects of mildronate orotate in the rat heart.
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Disease Models, Animal; Drug Synergism; Drug Ther

2009